Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 5Phase NA 2Phase 1 1

Status

Unknown 7Completed 5Recruiting 4Not yet recruiting 3Terminated 2

Sponsor Class

OTHER 5OTHER_GOV 2

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Carcinoma, Non-Small-Cell Lung 381Breast Neoplasms 364Colorectal Neoplasms 238Stomach Neoplasms 218Carcinoma, Hepatocellular 155Lung Neoplasms 123Neoplasms 120Pancreatic Neoplasms 109Prostatic Neoplasms 100Neoplasm Metastasis 96Recurrence 95Rectal Neoplasms 95Ovarian Neoplasms 90Nasopharyngeal Carcinoma 88Esophageal Neoplasms 82Esophageal Squamous Cell Carcinoma 81Lymphoma, Large B-Cell, Diffuse 79Melanoma 75Small Cell Lung Carcinoma 71Uterine Cervical Neoplasms 70Lymphoma 70Leukemia, Myeloid, Acute 70Brain Neoplasms 69Sarcoma 68Head and Neck Neoplasms 68Squamous Cell Carcinoma of Head and Neck 67Multiple Myeloma 65Carcinoma, Renal Cell 63Triple Negative Breast Neoplasms 61Lymphoma, Non-Hodgkin 53

Interventions

surufatinib 1regorafenib 1raltitrexed 1nimotuzumab 1endostar protein 1Oxaliplatin 1Irinotecan 1Drug Therapy 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Advanced Colorectal Cancer × Clear all
NCT02619435 2023-03-24

STREAM

National Cancer Institute, Naples

Phase 2 Unknown
46 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT04764006 2021-11-04

Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study

Fujian Cancer Hospital

Phase 2 Unknown
10 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT03126071 2021-08-30

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

Jiangsu Cancer Institute & Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT04324476 2021-08-30

A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer

Jiangsu Cancer Institute & Hospital

Phase 2 Unknown
50 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT04734249 2021-02-02

Second-line Surufatinib Combined With Chemotherapy in Advanced CRC

Fujian Cancer Hospital

Phase 2 Unknown
56 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT00853684 2009-09-18

OXCE

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
44 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT00972465 2009-09-07

Study of Nimotuzumab to Treat Colorectal Cancer

Peking University

Phase 2 Unknown
48 enrolled
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡